Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity
Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables Compounding Alert: June 7, 2019 Introduction FDA warned compounders on February 1, 2019, not to use glutathione L-reduced powder (L-glutathione) distributed by Letco Medical located in Decatur, Alabama, to compound sterile injectable drugs
Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I
[DOI] [PMC free article] [PubMed] [20].Montesano A, Senesi P, Vacante F, Mollica G, Benedini S, Mariotti M, et al
15: 950 Harle D, Baldo B, Wells J